Is screening for fetal anomalies reliable in HIV-infected pregnant women? A multicentre study

AIDS

Volumn 22, Issue 15, 2008, Pages 2013-2017

  Brossard, Philippe ^a,e   Boulvain, Michel ^a   Coll, Oriol ^b   Barlow, Patricia ^c   Aebi Popp, Karoline ^d   Bischof, Paul ^a   De Tejada, Begoña Martinez ^a   Aebi, C ^f   Battegay, M ^f   Bernasconi, E ^f   Boni J ^f   Brazzola, P ^f   Bucher, H C ^f   Burgisser Ph ^f   Calmy, A ^f   Cattacin, S ^f   Cavassini, M ^f   Cheseaux, J J ^f   Drack, G ^f   Dubs, R ^f   Egger, M ^f   Elzi, L ^f   Fischer, M ^f   Flepp, M ^f   Fontana, A ^f   Francioli, P ^f   Furrer, H J ^g   Fux, C ^g   Gayet Ageron, A ^g   Gerber, S ^g   Gorgievski, M ^g   Grawe, C ^g   Gunthard H ^g   Gyr, Th ^g   Hirsch, H ^g   Hirschel, B ^g   Hosli I ^g   Husler M ^g   Kaiser, L ^g   Kahlert, Ch ^g   Karrer, U ^g   Kind, C ^g   Klimkait, Th ^g   Ledergerber, B ^g   Martinetti, G ^g   Martinez, B ^g   Muller N ^g   Nadal, D ^g   Opravil, M ^g   Paccaud, F ^g   Pantaleo, G ^g   Rauch, A ^g   Regenass, S ^g   Rickenbach, M ^g   Rudin, C ^g   Schmid, P ^e   Schultze D ^e   Schupbach J ^e   Speck, R ^e   Taffe P ^e   Telenti, A ^e   Trkola, A ^e   Vernazza, P ^e   Weber, R ^e   Wunder, D ^e   Wyler, C A ^e   Yerly, S ^e   more..

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF BARCELONA   (Spain)

^c SAINT PIERRE UNIVERSITY HOSPITAL   (Belgium)

^d UNIVERSITY HOSPITAL BASEL   (Switzerland)

^e Centre Hospitalier Universitaire Vaudois ^*

^f LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^g UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

fetoprotein; human chorionic gonadotrophin; Down syndrome; HIV; Neural tube defects; Nuchal translucency; Pregnancy associated plasma protein A; Screening

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN BETA SUBUNIT; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE MARKER; DOWN SYNDROME; FEMALE; FIRST TRIMESTER PREGNANCY; GONADOTROPIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANT WOMAN; PRENATAL SCREENING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RELIABILITY; RISK ASSESSMENT; VIRUS LOAD;

ADULT; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; DOWN SYNDROME; FEMALE; FETAL DISEASES; HIV INFECTIONS; HUMANS; MASS SCREENING; NEURAL TUBE DEFECTS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY-ASSOCIATED PLASMA PROTEIN-A; PRENATAL DIAGNOSIS;

EID: 53549104130     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32830fbda3     Document Type: Article

References (13)

1. Borrell A, Casals E, Fortuny A, Farre MT, Gonce A, Sanchez A, et al. First-trimester screening for trisomy 21 combining biochemistry and ultrasound at individually optimal gestational ages. An interventional study. Prenat Diagn 2004; 24:541-545.
2. Spencer K, SouterV, Tul N, Snijders R, Nicolaides KH. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 1999; 13:231-237.
3. Yudin MH, Prosen TL, Landers DV. Multiple-marker screening in human immunodeficiency virus-positive pregnant women: screen positivity rates with the triple and quad screens. Am J Obstet Gynecol 2003; 189:973-976.
4. Gross S, Castillo W, Crane M, Espinosa B, Carter S, De Veaux R, et al. Maternal serum alpha-fetoprotein and human chorionic gonadotropin levels in women with human immunodeficiency virus. Am J Obstet Gynecol 2003; 188:1052-1056.
5. Einstein FH, Wright RL, Trentacoste S, Gross S, Merkatz IR, Bernstein PS. The impact of protease inhibitors on maternal serum screening analyte levels in pregnant women who are HIV positive. Am J Obstet Gynecol 2004; 191:1004-1008.
6. Evans Ml, Wapner RJ. Invasive prenatal diagnostic procedures 2005. Semin Perinatal 2005; 29:215-218.
7. Somigliana E, Bucceri AM, Tibaldi C, Alberico S, Ravizza M, Savasi V, et al. Early invasive diagnostic techniques in pregnant women who are infected with the HIV: a multicenter case series. Am J Obstet Gynecol 2005; 193:437-442.
8. HIV-infected pregnant women and vertical transmission in Europe since 1986. European Collaborative Study. AIDS 2001; 15:761-770.
9. UNAIDS. Report on the global AIDS epidemic: 4th global report. Geneva; UNAIDS; 2004.
10. Thorne C, Newell ML. Prevention of mother-to-child transmission of HIV infection. Curr Opin Infect Dis 2004; 17:247-252.
11. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
12. Coll O, Suy A, Hernandez S, Pisa S, Lonca M, Thorne C, et al. Prenatal diagnosis in human immunodeficiency virus-infected women: a new screening program for chromosomal anomalies. Am J Obstet Gynecol 2006; 194:192-198.
13. Neals D, Magriples U, Simpson J, Copel J. HIV and biochemical screening: is there a higher false positive rate in HIV population? Am J Obstet Gynecol 2001; 185 (Suppl):S189.